Victory Capital Management’s Q32 Bio QTTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,613
Closed -$938K 2777
2020
Q4
$938K Sell
4,613
-895
-16% -$173K ﹤0.01% 1816
2020
Q3
$1.06M Sell
5,508
-210
-4% -$47.1K ﹤0.01% 1674
2020
Q2
$1.56M Sell
5,718
-32,033
-85% -$8.54M ﹤0.01% 1528
2020
Q1
$10.6M Buy
37,751
+18,000
+91% +$5.51M 0.01% 1072
2019
Q4
$7.36M Sell
19,751
-1,530
-7% -$438K 0.01% 1093
2019
Q3
$6.93M Buy
21,281
+13,939
+190% +$4.74M 0.01% 1086
2019
Q2
$2.59M Buy
7,342
+2,776
+61% +$1.09M 0.01% 1072
2019
Q1
$2.28M Sell
4,566
-237
-5% -$106K 0.01% 1060
2018
Q4
$1.93M Sell
4,803
-83
-2% -$31.4K ﹤0.01% 1046
2018
Q3
$2.01M Sell
4,886
-372
-7% -$126K ﹤0.01% 1094
2018
Q2
$1.93M Sell
5,258
-298
-5% -$107K ﹤0.01% 1085
2018
Q1
$1.87M Buy
+5,556
New +$1.87M ﹤0.01% 1085

Other funds holding QTTB

Victory Capital Management's QTTB Position: Q1 2021 in Review

Victory Capital Management sold out of Q32 Bio (QTTB) in Q1 2021, closing a stake of 4,613 shares — an estimated $938K sold.

Victory Capital Management first reported a position in QTTB in Q1 2018 and held it in 12 quarters. The position peaked at $10.6M in Q1 2020. 109 funds tracked by Wall St. Rank hold QTTB as of Q1 2021.

  • Victory Capital Management reported no remaining Q32 Bio position as of Q1 2021 after selling out during the quarter.
  • Victory Capital Management sold 4,613 Q32 Bio shares in Q1 2021, an estimated $938K.
  • Victory Capital Management first reported a position in Q32 Bio in Q1 2018 and held it in 12 quarters.
  • Victory Capital Management's Q32 Bio position peaked at $10.6M in Q1 2020.
  • 109 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2021.

Based on Victory Capital Management's 13F filing for Q1 2021, filed 4 May 2021.